Found: 6 articles
Article | Edition |
---|---|
S.S. Dotsenko, L.N. Shilova
CLINICAL AND LABORATORY PREDICTORS OF EFFECTIVENESS OF BACKGROUND THERAPY IN RHEUMATOID ARTHRITIS
|
№19 / 2017 |
M.V. Shapina, I.L. Khalif, A.O. Golovenko, V.N. Kashnikov
FEATURES OF THE COURSE OF ULCERATIVE COLITIS DURING THERAPY WITH INFLIXIMAB
|
№15 / 2015 |
I.Yu. Zinchuk
PHARMACOECONOMIC ANALYSIS OF GENETICALLY ENGINEERED BIOLOGICAL PRODUCTS USED IN THE TREATMENT OF PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS
|
№7 / 2014 |
O.Z. Okhlobystina, O.S. Shifrin, L.N. Androsova, A.V. Korolev, Yu.O. Sidorina
CURRENT APPROACHES TO THE DIAGNOSIS AND TREATMENT OF ULCERATIVE COLITIS
|
№2 / 2014 |
I.V. Oktyabrskaya, I.B. Belyayeva
Effect Of Baseline And Biological Therapy On Clinical Activity Parameters, Quality Of Life And Psychological Status Of Patients With Early Rheumatoid Arthritis
|
№9 / 2011 |
Belousova E.A., Morozova N.A., Velikanov E.V., Gaganov L.E.
Infliximab In Ulcerative Colitis: Review Of Studies And Own Results
|
№2 / 2011 |